Diagnostic News and Research

RSS

Biomoda joins Saccomanno Research Institute to advance CyPath technology for cancer detection

Cancer diagnostics company Biomoda, Inc. is working with the Saccomanno Research Institute to advance Biomoda's patented system for measuring the photon emission rate of CyPath-stained cells to detect early-stage lung cancer.

8 Sep 2010

miacom diagnostics presents rapid detection method for pneumonia causing pathogens

miacom diagnostics specializes on the development and production of medical tests for the detection of acute infectious diseases. In addition to its existing sepsis kits miacom, diagnostics is now presenting a further CE-marked product based on the same proprietary technology. It is targeted at the rapid detection of clinically most relevant pneumonia causing pathogens.

7 Sep 2010

FDA grants IRIS clearance for analysis of synovial fluid with iQ200, iRICELL automated microscopy analyzers

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the analysis of synovial fluid as a new product application in its Body Fluids Module utilizing its iQ®200 and iRICELL® automated microscopy analyzers.

7 Sep 2010

NextGen executes agreement with MKMG to deploy EHR solution

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Mount Kisco Medical Group, PC (MKMG) to deploy NextGen Ambulatory EHR (Electronic Health Record), NextGen Practice Management, and the NextGen Patient portal.

7 Sep 2010

Study reveals high rate of parental depression in first year after child's birth

More than one-third of mothers and about one-fifth of fathers in the United Kingdom appear to experience an episode of depression between their child's birth and 12th year of age, with the highest rates in the first year after birth, according to a report posted online today that will appear in the November print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

7 Sep 2010

Protagen AG announces € 10.0 Million for second round of finance totaling

Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis announced today a second round of finance totalling a volume of € 10.0 Million.

7 Sep 2010

New blood signature test to diagnose, treat respiratory infections

Coughing and wheezing patients could someday benefit from quicker, more accurate diagnosis and treatment for respiratory infections such as flu, through a simple blood test, according to scientists.

7 Sep 2010

Consumers misinterpret low carbohydrate claims to have health benefits: Study

Food manufacturers advertise a variety of foods on grocery store shelves by using nutrient claims on the front of packaging. A study in the September/October issue of the Journal of Nutrition Education and Behavior evaluates how consumers are interpreting certain carbohydrate-related content claims and the effects of claims on consumer perceptions of food products. Findings from this study reveal that consumers misinterpret low carbohydrate claims to have health benefits and weight loss qualities beyond their nutrition facts.

7 Sep 2010

Study on bacteria may help to develop treatment method for osteomyelitis

A surface molecule on bacteria that instructs bone cells to die could be the target for new treatments for bone disease, says a scientist speaking at the Society for General Microbiology's autumn meeting today.

7 Sep 2010

Myconostica's MycAssay Aspergillus for serum granted CE marking

Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the CE marking of its lead product MycAssay™ Aspergillus for detection of Aspergillus DNA in serum.

6 Sep 2010

PennHIP radiographic method may hold potential to evaluate human susceptibility to hip dysplasia

A study comparing a University of Pennsylvania method for evaluating a dog's susceptibility to hip dysplasia to the traditional American method has shown that 80 percent of dogs judged to be normal by the traditional method are actually at risk for developing osteoarthritis and hip dysplasia, according to the Penn method.

4 Sep 2010

Human endogenous retroviruses may provide insight evidence to HIV diagnosis

Why is it so hard to isolate and purify human immunodeficiency virus (HIV).Why has no one been able to see, by electron microscopy, a single HIV particle in the blood of AIDS patients, even those who have a "high viral load" Why does HIV seem to mutate with startling rapidity. AIDS researchers have not been able to come up with answers to these questions.

4 Sep 2010

Study suggest PET/CT scanning may offer effective breast cancer detection, spread

About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread. Controversy continues to surround the question of whether CT and bone scans should be standard in evaluating patients for these metastases, or whether integrated PET/CT scanning might be more effective at detecting breast tumors that have reached nearby bones.

4 Sep 2010

CSI Laboratories to expand new diagnostic laboratory in Alpharetta

CSI Laboratories, a private national cancer diagnostic laboratory, today announced the lease of a new 65,000 square foot facility in Alpharetta, GA, located north of the city of Atlanta.

3 Sep 2010

Researchers develop new animal model for studying hemophilia A

Researchers at Yale School of Medicine have developed a new animal model for studying hemophilia A, with the goal of eventually treating people with the disorder.

3 Sep 2010

Researchers recommend health care organizations invest in time and resources for LSAEs disclosure

Health care organizations should disclose medical mistakes that affect multiple patients even if patients were not harmed by the event, according to an AHRQ-funded research paper published in the September 2 issue of the New England Journal of Medicine.

3 Sep 2010

Emerald BioStructures, SomaLogic announce strategic collaboration for SOMAmers

Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.

3 Sep 2010

Celldex Therapeutics regains worldwide rights to commercialize rindopepimut therapeutic cancer vaccine

Celldex Therapeutics, Inc. announced today it will regain full worldwide rights to develop and commercialize rindopepimut (CDX-110), effective November 1, 2010.

3 Sep 2010

Health care organizations should disclose medical errors that affect multiple patients: Researchers

3 Sep 2010

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.

3 Sep 2010

Diagnostic News and Research

Biomoda joins Saccomanno Research Institute to advance CyPath technology for cancer detection

miacom diagnostics presents rapid detection method for pneumonia causing pathogens

FDA grants IRIS clearance for analysis of synovial fluid with iQ200, iRICELL automated microscopy analyzers

NextGen executes agreement with MKMG to deploy EHR solution

Study reveals high rate of parental depression in first year after child's birth

Protagen AG announces € 10.0 Million for second round of finance totaling

New blood signature test to diagnose, treat respiratory infections

Consumers misinterpret low carbohydrate claims to have health benefits: Study

Study on bacteria may help to develop treatment method for osteomyelitis

Myconostica's MycAssay Aspergillus for serum granted CE marking

PennHIP radiographic method may hold potential to evaluate human susceptibility to hip dysplasia

Human endogenous retroviruses may provide insight evidence to HIV diagnosis

Study suggest PET/CT scanning may offer effective breast cancer detection, spread

CSI Laboratories to expand new diagnostic laboratory in Alpharetta

Researchers develop new animal model for studying hemophilia A

Researchers recommend health care organizations invest in time and resources for LSAEs disclosure

Emerald BioStructures, SomaLogic announce strategic collaboration for SOMAmers

Celldex Therapeutics regains worldwide rights to commercialize rindopepimut therapeutic cancer vaccine

Health care organizations should disclose medical errors that affect multiple patients: Researchers

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News